Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.

BACKGROUND Homocystinemia is a metabolic abnormality associated with endothelial dysfunction and increased cardiovascular disease risk. The underlying mechanisms of these effects, however, are obscure. OBJECTIVE We examined the effect of asymmetrical dimethylarginine (ADMA) on endothelial dysfunction in methionine-induced and chronic homocystinemia and evaluated the regulatory role of oxidative stress and proinflammatory cytokines on the release of ADMA. DESIGN In this double-blind, placebo-controlled parallel group study, 30 subjects of both sexes (15 with homocystinemia and 15 healthy controls) underwent methionine loading, with simultaneous administration of a combination of vitamin C (2 g) plus alpha-tocopherol (800 IU) or placebo. Endothelial function in forearm resistance vessels and concentrations of ADMA, oxidized LDL, and proinflammatory cytokines were determined at baseline and 4 h after methionine loading. RESULTS Both chronic and methionine-induced homocystinemia were associated with increased oxidized LDL (P < 0.01), higher expression of the proinflammatory cytokine interleukin 6 (P < 0.05), and endothelial dysfunction (P < 0.01). Although ADMA rapidly increased in acute homocystinemia (P < 0.01) and was correlated with forearm hyperemic response at 4 h after methionine loading (r = -0.722, P = 0.0001), it was not higher in subjects with high versus low fasting homocysteine. High-dose antioxidant treatment prevented methionine-induced elevation of oxidized LDL and interleukin 6 but failed to prevent the increase in ADMA or endothelial dysfunction. CONCLUSIONS Both chronic and methionine-induced homocystinemia are characterized by increased oxidative stress and proinflammatory cytokines, which may contribute to the development of endothelial dysfunction. However, the ADMA pathway is activated only in acute homocystinemia by mechanisms not mediated by oxidized LDL or proinflammatory stimuli.

[1]  C. Zoccali,et al.  Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  S. Henning,et al.  Bioavailability and antioxidant effects of orange juice components in humans. , 2005, Journal of agricultural and food chemistry.

[3]  C. Stefanadis,et al.  Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques , 2005, Heart.

[4]  Michael Weis,et al.  Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. , 2005, Clinical science.

[5]  O. Stanger,et al.  Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. , 2005, Current drug metabolism.

[6]  C. Stefanadis,et al.  Combined effects of smoking and hypercholesterolemia on inflammatory process, thrombosis/fibrinolysis system, and forearm hyperemic response. , 2004, The American journal of cardiology.

[7]  D. Bunout,et al.  Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. , 2004, The Journal of nutrition.

[8]  A. Nègre-Salvayre,et al.  Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway , 2004, Free radical research.

[9]  J. Cooke.  Asymmetrical Dimethylarginine: The Über Marker? , 2004, Circulation.

[10]  H. Valantine,et al.  Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis , 2004, Circulation.

[11]  D. Tsikas,et al.  Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans , 2004, Circulation.

[12]  Á. M. Patterson,et al.  No Evidence for Oxidative Stress as a Mechanism of Action of Hyperhomocysteinemia in Humans , 2004, Free radical research.

[13]  Yuan‐jian Li,et al.  Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level. , 2003, Planta medica.

[14]  James E. Novak,et al.  Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  T. Todros,et al.  Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro , 2003, Journal of hypertension.

[16]  C. Stefanadis,et al.  Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease. , 2003, Diabetes care.

[17]  S. Homer-Vanniasinkam,et al.  Effect of homocysteine on cytokine production by human endothelial cells and monocytes , 2003, Annals of clinical biochemistry.

[18]  J. Cooke,et al.  Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine , 2003, Circulation.

[19]  D. Remick,et al.  Homocysteine Mediated Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Monocytes , 2003, Circulation research.

[20]  V. Schini-Kerth.  Homocysteine, a proinflammatory and proatherosclerotic factor: role of intracellular reactive oxygen species. , 2003, Circulation research.

[21]  C. Napoli,et al.  Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. , 2003, Trends in molecular medicine.

[22]  T. Hedner,et al.  Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease , 2003, European journal of clinical investigation.

[23]  P. Aukrust,et al.  Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects , 2003, British Journal of Nutrition.

[24]  F. Faraci.  Hyperhomocysteinemia: a million ways to lose control. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Morimatsu,et al.  Regulation of Cytokine-Induced Nitric Oxide Synthesis by Asymmetric Dimethylarginine: Role of Dimethylarginine Dimethylaminohydrolase , 2003, Circulation research.

[26]  C. Woo,et al.  Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia: Role of Chemokine and Adhesion Molecules , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[28]  P. Vallance,et al.  S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. von Eckardstein,et al.  Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe. , 2001, Thrombosis research.

[30]  P. Stumbo,et al.  Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. , 2001, The American journal of cardiology.

[31]  L. T. McGrath,et al.  The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia , 2001, BMC cardiovascular disorders.

[32]  G. Kajiyama,et al.  Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. , 2001, Journal of the American College of Cardiology.

[33]  D. Webb,et al.  Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation. , 2001, Clinical science.

[34]  D. Tsikas,et al.  LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. , 2000, Circulation research.

[35]  D. Heistad,et al.  Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[36]  P. Reitsma,et al.  Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. , 2000, Blood Coagulation and Fibrinolysis.

[37]  J. Kooner,et al.  Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[38]  H. Knapp,et al.  Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. , 1999, Circulation.

[39]  P. Tsao,et al.  Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. , 1999, Circulation.

[40]  J. Kooner,et al.  Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy Demonstration of Rapid Onset Vascular Endothelial Dysfunction After , 1999 .

[41]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[42]  F. Neumann,et al.  Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein , 1997 .

[43]  M. Kimoto,et al.  Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats. , 1987, Biochemical and biophysical research communications.

[44]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[45]  K. Siala,et al.  The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. , 2005, Physiological research.

[46]  R. Boger.  Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. , 2005, Atherosclerosis.

[47]  D. Tsikas,et al.  ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. , 2003, Cardiovascular research.

[48]  D. Fliser,et al.  Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[49]  G. Kajiyama,et al.  A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. , 2001, The American journal of cardiology.

[50]  R. Wolf,et al.  Cytokine–Induced Alteration of Platelet and Hemostatic Function , 1996, Stem cells.